journal
MENU ▼
Read by QxMD icon Read
search

Cancer Management and Research

journal
https://www.readbyqxmd.com/read/29138597/characteristics-and-prognostic-factors-of-colorectal-mucinous-adenocarcinoma-with-signet-ring-cells
#1
Xiangquan Kong, Xueqing Zhang, Yunxia Huang, Lirui Tang, Qingqin Peng, Jinluan Li
Background: Colorectal signet ring cell (SRC) carcinoma occurs rarely with a poor prognosis. The present study assessed the prognostic factors and predictive value of SRC ratio in colorectal mucinous adenocarcinoma (MAC) with SRCs (MAC-SRC). Patients and methods: A total of 95 consecutive colorectal MAC-SRC patients, confirmed pathologically from February 1987 to December 2015, were analyzed retrospectively in our institute. Clinical characteristics, pathological grade, TNM staging, and SRC ratio were assessed to identify the prognostic factors related to progression-free survival (PFS) and overall survival (OS)...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29138596/nifuratel-a-novel-stat3-inhibitor-with-potent-activity-against-human-gastric-cancer-cells
#2
Hailun Zheng, Huang Hong, Lulu Zhang, Xiong Cai, Meng Hu, Yuepiao Cai, Bin Zhou, Jiayuh Lin, Chengguang Zhao, Wanle Hu
Activation of the signal transducer and activator of transcription 3 (STAT3) is observed in multiple cancer types, including gastric cancer, and represents a potential drug target for chemotherapy. Currently, clinically available small-molecule inhibitors targeting STAT3 are lacking. Here, we report that nifuratel, an antiprotozoal and antifungal drug, is a potent inhibitor of STAT3. We found that nifuratel significantly suppressed proliferation and induced apoptosis of gastric cancer cells. Studies of the mechanism of action of nifuratel indicated that it acts by inhibiting the constitutive and interleukin-6-induced STAT3 activation...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29138595/clinical-aspects-of-foot-health-and-their-influence-on-quality-of-life-among-breast-cancer-survivors-a-case-control-study
#3
Patricia Palomo-López, David Rodríguez-Sanz, Ricardo Becerro-de-Bengoa-Vallejo, Marta Elena Losa-Iglesias, Jorge Guerrero-Martín, Cesar Calvo-Lobo, Daniel López-López
Purpose: The aim of this study was to analyze and compare foot health and general health in a sample of women divided into two groups: 1) those with breast cancer and undergoing chemotherapy treatment and 2) healthy women without breast cancer and with normalized reference values. Methods: A case-control observational study was performed. Two-hundred women with a mean age of 51.00±8.75 years were recruited from podiatric medicine and surgery clinics from the University of Extremadura (Plasencia, Spain) and the Hospital Infanta Cristina (Badajoz, Spain)...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29123423/high-expression-of-eif3d-is-associated-with-poor-prognosis-in-patients-with-gastric-cancer
#4
Jiaqi He, Xuefei Wang, Jianhua Cai, Wei Wang, Xinyu Qin
Background: Eukaryotic initiation factor 3 subunit d (eIF3d) is the largest subunit of eIF3, which is shown to promote protein synthesis in cancer cells. Increased expression of eIF3d has been shown in some types of cancers, but has not been previously studied in gastric cancer (GC). Thus, the aim of this study was to analyze eIF3d expression in GC. Patients and methods: Expression of eIF3d was detected by immunohistochemistry in GC tissues and adjacent noncancerous (ANC) tissues...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29089785/partial-hepatectomy-for-spontaneous-tumor-rupture-in-patients-with-hepatocellular-carcinoma-a-retrospective-cohort-study
#5
Qian Zhu, Guo-Liang Qiao, Chang Xu, De-Liang Guo, Jie Tang, Rui Duan, Yun Li
BACKGROUND: The impact of ruptured hepatocellular carcinoma (HCC) on a patients outcome after hepatic resection remains insufficient. We aimed to identify the independent predictive factors of spontaneous tumor rupture (STR) for curative resection of HCC and to investigate the impact of STR of HCC on long-term survival after resection. PATIENTS AND METHODS: The clinicopathological parameters of 106 patients with ruptured HCC and 201 patients with non-ruptured HCC who underwent hepatic resection from 2007 to 2011 were investigated...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29089784/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-for-appendiceal-goblet-cell-carcinomas-with-peritoneal-carcinomatosis-results-from-a-single-specialized-center
#6
Hsin-Hsien Yu, Yutaka Yonemura, Mao-Chih Hsieh, Akiyoshi Mizumoto, Satoshi Wakama, Chang-Yun Lu
BACKGROUND: Goblet cell carcinomas (GCCs) of the appendix are rare and aggressive malignancies with early peritoneal dissemination. The aim of the present article is to describe our experience in the management of GCCs with peritoneal carcinomatosis (PC) through cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) and to determine the impact of multiple clinical characteristics on the prognosis. METHODS: From a prospectively maintained database of patients receiving CRS and HIPEC for peritoneal surface malignancy, the data of 15 patients with GCC and PC were collected...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29081671/extrahepatic-metastasis-risk-of-hepatocellular-carcinoma-based-on-%C3%AE-fetoprotein-and-tumor-staging-parameters-at-cross-sectional-imaging
#7
Takeshi Yokoo, Amish D Patel, Naama Lev-Cohain, Amit G Singal, Adam C Yopp, Ivan Pedrosa
BACKGROUND: Extrahepatic metastases have important implications in the clinical management of hepatocellular carcinoma (HCC). The purpose of this study was to validate tumor staging parameters and serum AFP as risk factors of HCC metastasis. PATIENTS AND METHODS: In this retrospective case-control study, patients with a new diagnosis of HCC (N=236), median age 57 years (range 28-89 years), and male-to-female ratio of 183/53 were divided into a "no-met" group (N=101) without extrahepatic metastasis or a "met" group with extrahepatic metastases (N=135)...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29075139/a-structured-group-exercise-program-for-patients-with-metastatic-cancer-receiving-chemotherapy-and-ctnnb1-%C3%AE-catenin-as-a-biomarker-of-exercise-efficacy
#8
James A Chiarotto, Riyad Akbarali, Lara Bellotti, George Dranitsaris
INTRODUCTION: Exercise can improve the symptoms of cancer. However, is it a cancer treatment? We tested the feasibility of group exercise for metastatic cancer patients while on chemotherapy. A biomarker for exercise efficacy in colorectal cancer (CRC), β-catenin, was tested. METHODS: Patients undergoing palliative chemotherapy were eligible for a pre-post, single-arm study comprising an indefinite, weekly group exercise intervention using strength and aerobic training...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29062241/interleukin-1-receptor-antagonist-inhibits-angiogenesis-via-blockage-il-1%C3%AE-pi3k-nf-%C3%AE%C2%BA%C3%AE-pathway-in-human-colon-cancer-cell
#9
Jiachi Ma, Xiaowen Sun, Tiankang Guo, He Su, Quan Chen, Zhenqiang Gong, Jianbo Qi, Xiaodan Zhao
PURPOSE: This article investigates the relationship between cancer cells and stromal cells in carcinoma cell living microenvironment and elucidates the mechanism that interleukin-1 receptor antagonist (IL-1RA) blocks metastatic potential in colon cancer. METHODS: Western blot and RT-PCR assay were used to determine the expression of hepatocyte growth factor (HGF) and IL-1α in colon carcinoma cells and stromal cells. Effect of IL-1RA and HGF on metastatic potential of colon cancer cells were examined by proliferation, invasion, and angiogenesis assays...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29056856/surgical-resection-of-a-primary-tumor-improves-survival-of-metastatic-pancreatic-cancer-a-population-based-study
#10
Lianyuan Tao, Chunhui Yuan, Zhaolai Ma, Bin Jiang, Dianrong Xiu
INTRODUCTION: Pancreatic cancer is a lethal disease with a very poor prognosis. This study investigates survival of patients diagnosed with metastatic pancreatic cancer (mPC) based on local treatment of the primary tumor. METHODS: Patients diagnosed with stage IV mPC between 2004 and 2013 were identified from the Surveillance, Epidemiology and End Results (SEER) database. Cancer-specific survival (CSS) and overall survival (OS) were examined. CSS and OS were examined by using the Kaplan-Meier method with the log-rank test...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29056855/emerging-combination-therapies-for-metastatic-colorectal-cancer-impact-of-trifluridine-tipiracil
#11
REVIEW
Jeevan M Puthiamadathil, Benjamin A Weinberg
Patients with metastatic colorectal cancer (mCRC) are surviving longer now than ever before, but mortality rates are still high and more effective therapies are clearly needed. For patients with disease that is refractory to fluoropyrimidines, oxaliplatin, irinotecan, and biologic agents targeting the vascular endothelial growth factor and epidermal growth factor receptor pathways, novel treatment options trifluridine/tipiracil (TAS-102) and regorafenib can be effective disease stabilizers. However, objective clinical responses are rare and toxicities are manageable but common...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29056854/postoperative-radiotherapy-for-invasive-micropapillary-carcinoma-of-the-breast-an-analysis-of-surveillance-epidemiology-and-end-results-database
#12
San-Gang Wu, Wen-Wen Zhang, Jia-Yuan Sun, Feng-Yan Li, Yong-Xiong Chen, Zhen-Yu He
INTRODUCTION: Invasive micropapillary carcinoma (IMPC) of the breast poses a high risk of locoregional recurrence, and postoperative radiotherapy (PORT) may be beneficial in IMPC. Hence, we determined the clinical value of PORT in IMPC patients. PATIENTS AND METHODS: We assessed clinicopathological factors extracted from the Surveillance, Epidemiology, and End Results database (2004-2013). Univariate and multivariate Cox proportional hazards regressions were performed to assess the independent prognostic factors on breast cancer-specific survival (BCSS) and overall survival (OS)...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29033609/clinical-implications-of-six-inflammatory-biomarkers-as-prognostic-indicators-in-ewing-sarcoma
#13
Yong-Jiang Li, Xi Yang, Wen-Biao Zhang, Cheng Yi, Feng Wang, Ping Li
Cancer-related systemic inflammation responses have been correlated with cancer development and progression. The prognostic significance of several inflammatory indicators, including neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), Glasgow Prognostic Score (GPS), C-reactive protein to albumin ratio (CRP/Alb ratio), lymphocyte-monocyte ratio (LMR), and neutrophil-platelet score (NPS), were found to be correlated with prognosis in several cancers. However, the prognostic role of these inflammatory biomarkers in Ewing sarcoma has not been evaluated...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29033608/is-the-prognostic-significance-of-o6-methylguanine-dna-methyltransferase-promoter-methylation-equally-important-in-glioblastomas-of-patients-from-different-continents-a-systematic-review-with-meta-analysis
#14
REVIEW
Wei Meng, Yangyang Jiang, Jie Ma
BACKGROUND: O6-methylguanine-DNA methyltransferase (MGMT) is an independent predictor of therapeutic response and potential prognosis in patients with glioblastoma multiforme (GBM). However, its significance of clinical prognosis in different continents still needs to be explored. PATIENTS AND METHODS: To explore the effects of MGMT promoter methylation on both progression-free survival (PFS) and overall survival (OS) among GBM patients from different continents, a systematic review of published studies was conducted...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/29026335/challenging-the-standard-of-care-in-advanced-melanoma-focus-on-pembrolizumab
#15
REVIEW
Raghad M Abdul-Karim, C Lance Cowey
The last several years have seen a dramatic rise in the number of effective therapies that have been shown to improve survival outcomes for patients with advanced melanoma. Among these treatments are the immune checkpoint inhibitors, a new class of immunotherapy, that have demonstrated the ability to improve both response rates and survival outcomes. Pembrolizumab, an immune checkpoint inhibitor that blocks the negative regulatory PD-1 receptor on T-cell lymphocytes, has shown improved efficacy compared to standard therapies with an acceptable tolerability profile...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/28989285/unintended-target-effect-of-anti-bcl-2-dnai
#16
Abdul Shukkur Ebrahim, Mustapha Kandouz, Nada Emara, Amara B Sugalski, Leonard Lipovich, Ayad M Al-Katib
INTRODUCTION: Previous research suggested that a novel compound PNT2258 inhibits B-cell lymphoma 2 (BCL-2) transcription by DNA interference (DNAi) and demonstrated its activity in preclinical xenograft models and in a pilot Phase II clinical trial in non-Hodgkin's lymphoma (NHL). While the drug downregulates BCL-2 at the promoter, mRNA, and protein levels, there is a significant homology (13-16 bases) between PNT100 and a number of promoters of genes involved in cell cycle regulation and survival...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/28979163/a-p53-regulated-apoptotic-gene-signature-predicts-treatment-response-and-outcome-in-pediatric-acute-lymphoblastic-leukemia
#17
Russell O Bainer, Matthew R Trendowski, Cheng Cheng, Deqing Pei, Wenjian Yang, Steven W Paugh, Kathleen H Goss, Andrew D Skol, Paul Pavlidis, Ching-Hon Pui, T Conrad Gilliam, William E Evans, Kenan Onel
Gene signatures have been associated with outcome in pediatric acute lymphoblastic leukemia (ALL) and other malignancies. However, determining the molecular drivers of these expression changes remains challenging. In ALL blasts, the p53 tumor suppressor is the primary regulator of the apoptotic response to genotoxic chemotherapy, which is predictive of outcome. Consequently, we hypothesized that the normal p53-regulated apoptotic response to DNA damage would be altered in ALL and that this alteration would influence drug response and treatment outcome...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/28919818/standard-of-care-and-direct-medical-costs-of-the-treatment-of-chronic-lymphocytic-leukemia-among-the-adult-population-in-ukraine-russia-and-kazakhstan-data-from-the-leukospect-study
#18
Averyan Vasylyev, Valentina Molostvova, Boris A Rebrov, Janina Makarova, Andrey Zaritskey, Vadim Ptushkin, Raigul Ramazanova, Yuriy Popovych, Orest Tsyapka, Evgeny Pashanov
PURPOSE: The LEUKOSPECT study aimed to describe health service utilization and to estimate the direct medical costs (DMCs) of chronic lymphocytic leukemia (CLL) in 2013 in the adult population of three post-Soviet countries - Russia, Ukraine, and Kazakhstan. As oncologic medical care is provided by federal state-owned, specialized medical institutions, the cost estimation in this study primarily informs from a state budget perspective. Patients' contributions to medical costs were not included in the cost evaluation...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/28919817/sirt1-gene-polymorphisms-and-risk-of-lung-cancer
#19
Yanbo Lv, Shuangyan Lin, Fang Peng
OBJECTIVE: Lung cancer, which is the leading cause of cancer death worldwide, is influenced by a wide variety of environmental and genetic risk factors. The silent information regulator 1 (SIRT1) gene is located on the long arm of chromosome 10 (10q21.3) and has been shown to play crucial roles in lung cancer development in previous studies. In this study, we determined whether variation in the SIRT1 gene is associated with lung cancer in Chinese population. METHODS: The case-control study comprised 246 controls and 257 non-small cell lung cancer patients, comprising 79 squamous cell carcinoma patients and 124 adenocarcinoma patients...
2017: Cancer Management and Research
https://www.readbyqxmd.com/read/28883741/treatment-and-prognostic-factors-for-survival-in-newly-diagnosed-multiple-myeloma-patients-with-bortezomib-and-dexamethasone-regimen-a-single-chinese-center-retrospective-study
#20
Runzhe Chen, Xiaoping Zhang, Chong Gao, Chengxin Luan, Yujie Wang, Baoan Chen
OBJECTIVE: The aim of this retrospective study was to evaluate the efficacy and prognostic factors of bortezomib and dexamethasone (BD) chemotherapy regimen in the treatment of newly diagnosed multiple myeloma (MM) patients in our hospital. METHODS: A total of 47 newly diagnosed MM patients treated in our hospital from May 2010 to September 2016 were included in this study. All the enrolled patients received at least two cycles of BD chemotherapy regimen. RESULTS: The overall response rate after treatment was 68...
2017: Cancer Management and Research
journal
journal
42502
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"